NIH scientists describe potential antibody approach for treating multidrug-resistant Klebsiella pneumoniae — Promising concept may lead to an alternative to antibiotics [NIH/NIAID news, 13 Mar 2018]

Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide, allowing immune system cells called neutrophils to attack and kill the bacteria. The early stage, in vitro research was conducted by scientists at NIAID?s Rocky Mountain Laboratories and the New Jersey Medical School-Rutgers University.

https://www.niaid.nih.gov/news-events/nih-scientists-describe-potential-antibody-approach-treating-multidrug-resistant

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →